---
title: "Recommendation: Safeguarding Patients in Clinical Trials with High Mortality Rates"
author: "Steve Simon"
source: "http://blog.pmean.com/safeguarding/"
date: "2015-12-02"
category: Blog post
tags: Blinding in research, Early stopping, Ethics in research
output: html_document
---

This is an article the I would trot out if anyone tried to argue that a
Data Safety and Monitoring Board should, like the investigators, be
blinded as to treatment status during their deliberations.

<!---More--->

BRADLEY D. FREEMAN, ROBERT L. DANNER, STEVEN M. BANKS, and CHARLES
NATANSON "Safeguarding Patients in Clinical Trials with High Mortality
Rates", American Journal of Respiratory and Critical Care Medicine, Vol.
164, No. 2 (2001), pp. 190-192. doi: 10.1164/ajrccm.164.2.2011028.
Available at
<http://www.atsjournals.org/doi/full/10.1164/ajrccm.164.2.2011028>.

![](../../../web/images/15/safeguarding01.png)




